18F-FDG PET/CT radiomics across treatment timepoints for predicting response to neoadjuvant therapy in locally advanced esophageal cancer: a systematic review and meta-analysis
Pathological complete response (pCR) after neoadjuvant therapy is achieved in only about 20%–40% of patients with locally advanced esophageal cancer (LAEC), yet it is the strongest determinant of long-term survival. 18 F-fluorodeoxyglucose ( 18 F-FDG) positron emission tomography/computed tomography (PET/CT)...